Skye Bioscience's total assets for Q3 2024 were $81.54M, a decrease of -6.56% from the previous quarter. SKYE total liabilities were $5.73M for the fiscal quarter, a -60.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.